{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:22:09Z","timestamp":1793748129666,"version":"4.6.1"},"reference-count":164,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.clindermatol.2011.03.005","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T19:19:07Z","timestamp":1323371947000},"page":"3-16","source":"Crossref","is-referenced-by-count":129,"title":["Bullous pemphigoid: From the clinic to the bench"],"prefix":"10.1016","volume":"30","author":[{"given":"Giovanni","family":"Di Zenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"della Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Zambruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Borradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2011.03.005_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000316104","article-title":"\u2018Bullous\u2019 pemphigoid: what are you? Urgent need of definitions and diagnostic criteria","volume":"221","author":"Lipsker","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous diseases French study group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: a population based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Autoimmune bullous disease Swiss study group. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0030","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2014incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaad.2007.08.010","article-title":"Bullous pemphigoid in infancy: Clinical and epidemiologic characteristics","volume":"58","author":"Waisbourd-Zinman","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-4362.1986.tb03397.x","article-title":"Clinical variants of pemphigoid","volume":"25","author":"Liu","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0190-9622(87)70115-7","article-title":"Bullous pemphigoid","volume":"16","author":"Korman","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0060","first-page":"73","article-title":"Atypical clinical forms of bullous pemphigoid","volume":"117","author":"Castanet","year":"1990","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archderm.1987.01660270127031","article-title":"Localized bullous pemphigoid. A mimic of acute contact dermatitis","volume":"123","author":"Salomon","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0070","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-4632.2004.02288.x","article-title":"Localized bullous pemphigoid: a commonly delayed diagnosis","volume":"44","author":"Tran","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000250069","article-title":"Develop of localized pemphigoid following radiation treatment","volume":"164","author":"Ernst","year":"1982","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0190-9622(92)70268-K","article-title":"Localized pretibial pemphigoid and pemphigoid nodularis","volume":"27","author":"Borradori","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2340\/0001555573461464","article-title":"Localized atypical pemphigoid on lymphoedema following radiotherapy","volume":"73","author":"Callens","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-4362.1983.tb03375.x","article-title":"Hydrostatic bullae and pretibial pemphigoid","volume":"22","author":"Person","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2340\/00015555-0644","article-title":"Bullous pemphigoid with localized umbilical involvement","volume":"89","author":"Schmidt","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0190-9622(88)80322-0","article-title":"Dyshidrosiform pemphigoid","volume":"19","author":"Nunzi","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0190-9622(08)80798-0","article-title":"Dyshidrosiform pemphigoid: report of three cases","volume":"26","author":"Descamps","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2133.1999.02668.x","article-title":"Childhood vulval pemphigoid: a clinical and immunopathological study of five patients","volume":"140","author":"Farrell","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0115","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archderm.1976.01630340020005","article-title":"Vesicular pemphigoid","volume":"112","author":"Bean","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0120","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-4362.1992.tb03546.x","article-title":"Vesicular pemphigoid","volume":"31","author":"Komine","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2133.2000.03434.x","article-title":"A vesicular bullous pemphigoid with an autoantibody against plectin","volume":"142","author":"Ohnishi","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2133.1989.tb04173.x","article-title":"Pemphigoid vegetans","volume":"120","author":"Ueda","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0135","first-page":"616","article-title":"Pigmented pemphigoid","volume":"126","author":"Poulain","year":"1999","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0140","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1365-2133.1995.tb06935.x","article-title":"Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid","volume":"133","author":"Korman","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0145","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2133.1997.tb14953.x","article-title":"Pemphigoid nodularis: a report of three cases and review of the literature","volume":"136","author":"Cliff","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0150","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000246158","article-title":"Pemphigoid presenting as atypical excoriated prurigo: regarding 11 cases","volume":"194","author":"Gengoux","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0155","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0190-9622(98)70358-5","article-title":"Bullous pemphigoid presenting as exfoliative erythroderma","volume":"39","author":"Alonso-Llamazares","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2133.2002.465611.x","article-title":"Extensive erosive bullous pemphigoid: an atypical and serious clinical variant","volume":"146","author":"Cordel","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000316098","article-title":"Ecthyma-gangrenosum-like bullous pemphigoid","volume":"221","author":"Geiss Steiner","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.1975.tb06497.x","article-title":"Coexistence of lichen planus and bullous pemphigoid. An immunopathological study","volume":"93","author":"Stingl","year":"1975","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0175","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1976.01630330042011","article-title":"Lichen planus pemphigoides, immunofluorescence findings","volume":"112","author":"Sobel","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0180","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0190-9622(99)70481-0","article-title":"Childhood bullous pemphigoid. Report of a case with characterization of the targeted antigens","volume":"40","author":"Trueb","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0185","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","article-title":"Drugs associated with bullous pemphigoid. A case-control study","volume":"132","author":"Bastuji-Garin","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0190","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk Factors for bullous pemphigoid in the elderly. A prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0190-9622(93)70164-O","article-title":"Bullous pemphigoid and autoimmunity","volume":"29","author":"Taylor","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0200","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2133.1996.tb03883.x","article-title":"Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study","volume":"135","author":"Kirtschig","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0205","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-4632.2006.02861.x","article-title":"Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?","volume":"45","author":"Wilczek","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2230.2010.03878.x","article-title":"Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?","volume":"36","author":"Shipman","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.1990.01670250072011","article-title":"Pemphigoid and cancer","volume":"126","author":"Lindelof","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0923-1811(94)00371-K","article-title":"The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan","volume":"9","author":"Ogawa","year":"1995","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0151-9638(05)79220-6","article-title":"Bullous pemphigoid in young patients: a retrospective study of 74 cases","volume":"132","author":"Bourdon-Lanoy","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0230","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archdermatol.2010.322","article-title":"The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study","volume":"146","author":"Taghipour","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0235","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0240","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1684\/ejd.2010.0805","article-title":"Bullous pemphigoid and internal diseases\u2014A case-control study","volume":"20","author":"Jedlickova","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0245","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/1352458508088936","article-title":"Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark","volume":"14","author":"Nielsen","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0250","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458510369146","article-title":"Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study","volume":"16","author":"Langer-Gould","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0255","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200012098","article-title":"The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles","volume":"154","author":"Leung","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2007.04.073","article-title":"Distribution of collagen XVII in the human brain","volume":"1158","author":"Seppanen","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0265","article-title":"Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain","author":"Chen","year":"2010","journal-title":"Gerontology"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(95)90333-X","article-title":"Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration","volume":"81","author":"Guo","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0275","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0280","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000075040","article-title":"Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera","volume":"208","author":"Joly","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0285","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaad.2008.06.022","article-title":"The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease","volume":"59","author":"Magro","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0290","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1600-0560.2009.01450.x","article-title":"C3d immunohistochemistry on formalin-fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin","volume":"37","author":"Pfaltz","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0295","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0190-9622(90)70094-X","article-title":"Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita","volume":"22","author":"Gammon","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0300","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","article-title":"U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases","volume":"151","author":"Vodegel","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archderm.1996.03890260053008","article-title":"Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping","volume":"132","author":"De Jong","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0310","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1523-1747.ep12259692","article-title":"Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin","volume":"82","author":"Gammon","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0315","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/1523-1747.ep12338088","article-title":"A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating autoantibodies in patients with bullous pemphigoid","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0320","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.1998.02396.x","article-title":"Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins","volume":"139","author":"Nakatani","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0325","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s004030050478","article-title":"Development of a system for detection of circulating antibodies against hemdesmosomal proteins in patients with bullous pemphigoid","volume":"292","author":"Husz","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0330","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0923-1811(00)00074-8","article-title":"Production of the entire extracellular domain of BP180 (type XVII collagen) by baculovirus expression","volume":"23","author":"Hata","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0335","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0340","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0345","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2133.2004.06082.x","article-title":"Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid","volume":"151","author":"Sakuma-Oyama","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0350","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0355","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180 specific autoantibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0360","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","article-title":"Development of an ELISA for the detection of autoantibodies to BP230","volume":"111","author":"Kromminga","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0365","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdermsci.2004.10.007","article-title":"Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid","volume":"37","author":"Tsuji-Abe","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0375","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-4632.2007.03531.x","article-title":"Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China","volume":"47","author":"Feng","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0385","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.04630.x","article-title":"Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid","volume":"1173","author":"Tampoia","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0390","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","article-title":"Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients","volume":"147","author":"Charneux","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0395","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archdermatol.2011.21","article-title":"Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid","volume":"147","author":"Roussel","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0400","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archdermatol.2009.53","article-title":"Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study","volume":"145","author":"Bernard","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0405","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0410","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0022-202X.2004.22504.x","article-title":"Mortality rate of bullous pemphigoid in a US medical center","volume":"122","author":"Colbert","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0415","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0420","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0425","first-page":"751","article-title":"[Survival prognosis in pemphigoid. A cohort analysis of 78 patients]","volume":"122","author":"Bernard","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0430","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.0022-202X.2005.23628.x","article-title":"Sepsis associated with dermatologic hospitalization is not the cause of high mortality of bullous pemphigoid in Europe","volume":"124","author":"Garcia-Doval","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0435","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0733-8635(05)70153-4","article-title":"New and emerging therapies in the treatment of blistering diseases","volume":"18","author":"Korman","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0440","first-page":"677","article-title":"Fiche th\u00e9rapeutique: prise en charge de la pemphigo\u00efde bulleuse","volume":"128","author":"Laffitte","year":"2001","journal-title":"Ann Dermatol Venerol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0445","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"Bullous Diseases French Study Group: a comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0450","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0455","first-page":"925","article-title":"Treatment of bullous pemphigoid with prednisolone only: 0.75 mg\/kg\/day versus 1.25 mg\/kg\/day. A multicenter randomized study","volume":"111","author":"Morel","year":"1984","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0460","first-page":"518","article-title":"Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study","volume":"120","author":"Dreno","year":"1993","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0465","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2133.1978.tb15207.x","article-title":"A controlled trial of azathioprine in the treatment of pemphigoid [proceedings]","volume":"99","author":"Burton","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0470","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1993.01680220061016","article-title":"Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid","volume":"129","author":"Guillaume","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0475","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0480","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1989.tb07769.x","article-title":"Dapsone as first line therapy for bullous pemphigoid","volume":"120","author":"Venning","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0485","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"6","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0490","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.annder.2008.10.038","article-title":"Efficacy of rituximab in a case of refractory bullous pemphigoid","volume":"136","author":"Reguia\u00ef","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0495","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1523-1747.1998.00126.x","article-title":"Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2","volume":"110","author":"Haase","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0500","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibdies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0505","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1523-1747.1999.00546.x","article-title":"Structure and function of hemidesmosomes: more than simple adhesion complexes","volume":"112","author":"Borradori","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0510","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1172\/JCI115054","article-title":"Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180","volume":"87","author":"Giudice","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0515","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1523-1747.ep12616615","article-title":"Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization","volume":"99","author":"Hopkinson","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0520","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI117785","article-title":"180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa","volume":"95","author":"Jonkman","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0525","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng0995-83","article-title":"Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa","volume":"11","author":"McGrath","year":"1995","journal-title":"Nature Genet"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0530","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI113803","article-title":"Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies","volume":"82","author":"Stanley","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0535","doi-asserted-by":"crossref","first-page":"17784","DOI":"10.1016\/S0021-9258(18)55195-4","article-title":"Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains","volume":"266","author":"Sawamura","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0540","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0141-8130(05)80004-2","article-title":"Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments","volume":"14","author":"Green","year":"1992","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0545","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/jid.2010.19","article-title":"A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex","volume":"130","author":"Groves","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0550","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI114812","article-title":"Isolation of a human epidermal cDNA corresponding to the 180-kDa autoantigen recognized by bullous pemphigoid and herpes gestationis sera","volume":"86","author":"Diaz","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0555","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.151.10.5742","article-title":"Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain","volume":"151","author":"Giudice","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0560","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/1523-1747.ep12382738","article-title":"Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis","volume":"102","author":"Giudice","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0565","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.1999.00497.x","article-title":"IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domain of the BP antigen 180","volume":"112","author":"Perriard","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0570","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1523-1747.1999.00501.x","article-title":"IgA antibodies of cicatricial pemphigoid sera specifically react with terminus of BP180","volume":"112","author":"Nie","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0575","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1523-1747.1999.00490.x","article-title":"Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain","volume":"112","author":"Egan","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0580","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0002-9440(10)64772-4","article-title":"The shed ectodomain of collagen XVII\/BP180 is targeted by autoantibodies in different blistering skin diseases","volume":"156","author":"Schumann","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0585","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1523-1747.2001.01246.x","article-title":"IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain","volume":"116","author":"Egan","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0590","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0595","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Auto-reactive T and B cells from bullous pemphigoid (BP) patients recognize similar antigenic regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0600","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomain of the COOH-terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0605","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1600-0625.2001.100405.x","article-title":"Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule","volume":"10","author":"Hamada","year":"2001","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0610","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/1523-1747.ep12484223","article-title":"Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins","volume":"97","author":"Tanaka","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0615","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1523-1747.ep12371694","article-title":"IgG antibodies from patients with bullous pemphigoid bind to fusion proteins encoded by BPAg1 cDNA","volume":"101","author":"Miller","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0620","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0625.1995.tb00232.x","article-title":"Detection of autoantibodies against the bullous pemphigoid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins","volume":"5","author":"Ide","year":"1995","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0625","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2133.1995.tb05012.x","article-title":"Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein. Evidence using a 55 kDa recombinant protein","volume":"132","author":"Gaucherand","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0630","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1023\/A:1020531005776","article-title":"IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)","volume":"18","author":"Ghohestani","year":"1998","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0635","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2133.2000.03661.x","article-title":"IgG, IgA and IgE antibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis","volume":"143","author":"Christophoridis","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0640","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.0022-202X.2005.23853.x","article-title":"Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid","volume":"125","author":"Fairley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0645","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","article-title":"A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid","volume":"346","author":"Messingham","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0650","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2133.2008.08858.x","article-title":"IgE autoantibodies against the intracellular domain of BP180","volume":"160","author":"Dresow","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0655","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"B\u00fcdinger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0660","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.162.8.4991","article-title":"Identification and characterization of epitopes recognized by T lymphocytes and autoantibodies from patients with herpes gestationis","volume":"162","author":"Lin","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0665","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1*0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0670","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000236199","article-title":"Human Th1 and Th2 subsets: regulation of differentiation and role in protection and immunopathology","volume":"98","author":"Romagnani","year":"1992","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0675","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0090-1229(90)90060-4","article-title":"Immunoblot analysis of IgG subclass of circulating antibodies in bullous pemphigoid","volume":"54","author":"Bernard","year":"1990","journal-title":"Clin Immunol Immunopath"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0680","first-page":"123","article-title":"Cytokines and bullous pemphigoid","volume":"10","author":"D'Auria","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0685","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0690","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0695","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1172\/JCI119639","article-title":"A major role for neutrophils in experimental bullous pemphigoid","volume":"100","author":"Liu","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0700","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1084\/jem.188.3.475","article-title":"Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid","volume":"188","author":"Liu","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0705","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI3693","article-title":"A critical role for neutrophil elastase in experimental bullous pemphigoid","volume":"105","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0710","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0092-8674(00)00087-8","article-title":"The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B\/MMP-9 in vivo","volume":"102","author":"Liu","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0715","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI23977","article-title":"Synergy between a plasminogen cascade and MMP-9 in autoimmune disease","volume":"115","author":"Liu","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0720","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0725","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.0022-202x.2001.01683.x","article-title":"Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid","volume":"118","author":"Yamamoto","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0730","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0735","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.4049\/jimmunol.0800389","article-title":"A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies","volume":"183","author":"Nishie","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0740","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1523-1747.ep12261694","article-title":"Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods","volume":"83","author":"Gammon","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0745","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180 kD in bullous pemphigoid autoantigen","volume":"93","author":"Stahle-B\u00e4ckdahl","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0750","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.0022-202x.2001.01521.x","article-title":"Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid","volume":"117","author":"Verraes","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0755","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/path.1674","article-title":"Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid","volume":"204","author":"Shimanovich","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0760","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1172\/JCI17891","article-title":"Role of different pathways of the complement cascade in experimental bullous pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0765","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI11494","article-title":"Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0770","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.4049\/jimmunol.169.7.3987","article-title":"Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophilinfiltration depends on mast cell activation","volume":"169","author":"Chen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0775","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1523-1747.2002.01720.x","article-title":"Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin","volume":"118","author":"Sitaru","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0780","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.177.5.3398","article-title":"Role of FcRs in animal model of autoimmune bullous pemphigoid","volume":"177","author":"Zhao","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0785","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.2003.12146.x","article-title":"Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid","volume":"120","author":"Dimson","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0790","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0795","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0800","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1523-1747.ep12358276","article-title":"Rabbits immunized with a peptide encoded for by the 230-kd bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid","volume":"101","author":"Hall","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2004.09.007","article-title":"Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230","volume":"24","author":"Kiss","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0810","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/jid.2009.309","article-title":"Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model","volume":"130","author":"Di Zenzo","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0815","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1038\/sj.jid.5700970","article-title":"Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice","volume":"127","author":"Olasz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.03.005_bb0820","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J Immunol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T16:06:24Z","timestamp":1713197184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X11000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0738081X11000812"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2011.03.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}